Therapeutic apheresis in transplantation: Overview and critical evaluation of available modalities in respect to indications, evidence and costs;Therapeutische apherese in der transplantationsmedizin: Kritische beurteilung der verfügbaren verfahren hinsichtlich indikationen, evidenz und kosten

Transplantationsmedizin: Organ der Deutschen Transplantationsgesellschaft

Volumn 22, Issue 4, 2010, Pages 266-272

  Teschner, S ^a   Kurschat, C ^a   Burst, V ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

ABO incompatible; Antibody mediated rejection; Costs; Desensitization; Donor specific antibody; Immunoadsorption; Kidney transplantation; Luminex; Plasmapheresis

Indexed keywords

EID: 78650198016     PISSN: 09469648     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Daugirdas JT, Blake PG, Ing TS (2001) Handbook of Dialysis, 3rd edition, Chapter 11: Plasmapheresis (pp. 234-235). Lippincott: Williams & Wilkins.
2. Ichimaru N, Takahara S (2008) Japan's experience with living-donor kidney transplantation across ABO barriers. Nature clinical practice Nephrology 4: 682-92.
3. Sawada T, Fuchinoue S, Teraoka S (2002) Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis. Transplantation 74: 1207-10.
4. Gloor JM, Lager DJ, Moore SB et al. (2003) ABO-incompatible kidney transplantation using both A2 and non-A2 living donors. Transplantation 75: 971.
5. Tydén G, Kumlien G, Fehrman I (2003) Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab. Transplantation 76: 730-1.
6. Claas FHJ, Rahmel A, Doxiadis IIN (2009) Enhanced kidney allocation to highly sensitized patients by the acceptable mismatch program. Transplantation 88: 447-52.
7. Haas M, Boehmig GA, Leko-Mohr Z et al. (2002) Perioperative immunoadsorption in sensitized renal transplant recipients. Nephrol Dial Transplant 17: 1503-8.
8. Vo A, Lukovsky M, Toyoda M et al. (2008) Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med 359: 242-51.
9. Jordan SC, Vo A, Bunnapradist S et al. (2003) Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in livingdonor and cadaver recipients. Transplantation 76: 631-6.
10. Jordan SC, Tyan D, Stablein D et al. (2004) Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with endstage renal disease: report of the NIH IG02 trial. J Am Soc Nephrol 15: 3256-62.
11. Gloor JM, DeGoey SR, Pineda AA et al. (2003) Overcoming a positive crossmatch in living-donor kidney transplantation. Am J Transplant 3: 1017-23.
12. Takemoto SK, Zeevi A, Feng S et al. (2004) National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 4: 1033-41.
13. Böhmig GA, Wahrmann M, Regele H et al. (2007) Immunoadsorption in severe C4d-positive acute kidney allograft rejection: a randomized controlled trial. Am J Transplant 7: 117-21.
14. Rocha PN, Butterly DW, Greenberg A et al. (2003) Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection. Transplantation 75: 1490-5.
15. Adams MB, Kauffman HM Jr, Hussey CV et al. (1981) Plasmapheresis in the treatment of refractory renal allograft rejection. Transplant Proc 13: 491-494.
16. Takemoto SK, Zeevi A, Feng S et al. (2004) National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 4: 1033-41.
17. Bell WR, Braine HG, Ness PM, Kickler TS (1991) Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med 325: 398-403.
18. Agarwal A, Mauer SM, Matas AJ, Nath KA (1995) Recurrent hemolytic uremic syndrome in an adult renal allograft recipient: current concepts and management. J Am Soc Nephrol 6: 1160-9.
19. George JN (2006) Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med 354: 1927.
20. George JN, Gilcher RO, Smith JW, Chandler L, Duvall D, Ellis C (1998) Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: diagnosis and management. J Clin Apheresis 13: 120-5.
21. Lahlou A, Lang P, Charpentier B et al. (2000) Hemolytic uremic syndrome. Recurrence after renal transplantation. Groupe Cooperatif de l'Ile-de-France (GCIF). Medicine (Baltimore) 79: 90-102.
22. Kasper S, Neurath MF, Huber C, Theobald M, Scharrer I (2007) Protein A immunoadsorption therapy for refractory, mitomycin C-associated thrombotic microangiopathy. Transfusion 47: 1263-7.
23. Mistry B, Kimmel PL, Hetzel PC, Phillips TM, Braden GL (2004) The role of circulating immune complexes and biocompatibility of staphylococcal protein A immunoadsorption in mitomycin C-induced hemolytic uremic syndrome. Am J Kidney Dis 44: e50-8.
24. Byrne MC, Budisavljevic MN, Fan Z, Self SE, Ploth DW (2002) Renal transplant in patients with Alport's syndrome. Am J Kidney Dis 39: 769-75.
25. Kashtan CE, Michael A (1996) Alport syndrome. Kidney Int 50: 1445.
26. Kalluri R, Weber M, Netzer KO, Sun MJ, Neilson EG, Hudson BG (1994) COL4A5 gene deletion and production of post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome. Kidney Int 45: 721-6.
27. Bolton WK (1996) Goodpasture's syndrome. Kidney Int 50: 1753.
28. Laczika K, Knapp S, Derfler K, Soleiman A, Horl WH, Druml W (2000) Immunoadsorption in Goodpasture's syndrome. Am J Kidney Dis 36: 392-5.
29. Bygren P, Freiburghaus C, Lindholm T, Simonsen O, Thysell H, Wieslander J (1985) Goodpasture's syndrome treated with staphylococcal protein A immunoadsorption. Lancet 8467: 1295-6.
30. Dantal J, Bigot E, Bogers W et al. (1994) Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 330: 7-14.
31. Dall'Amico R, Ghiggeri G, Carraro M et al. (1999) Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. Am J Kidney Dis 34: 1048-55.
32. Artero ML, Sharma R, Savin VJ, Vincenti F (1994) Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 23: 574-81.
33. Geyer M, Fischer KG, Drognitz O, Walz G, Pisarski P, Wilpert J (2009) ABO-incompatible kidney transplantation with antigen-specific immunoadsorption and rituximab - insights and uncertainties. Contributions to nephrology 162: 47-60.